Advanced lung adenocarcinoma in an EGFR-positive patient treated with Erlotinib for 52 months
The authors present a case of a 53-years-old non-smoker Caucasian female who was diagnosed with lung adenocarcinoma (stage IA) and underwent surgical resection in 2002. Five years later, the tumor relapsed (stage IV disease) and she initiated chemotherapy with carboplatin, gemcitabine and bevacizuma...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Elsevier
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920415/ |